The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia by Christine Le Roy, Pierre-Antoine Deglesne, Nathalie.

Slides:



Advertisements
Similar presentations
Volume 132, Issue 3, Pages (March 2007)
Advertisements

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia by Marco Herling, Kaushali.
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33 by Tatjana Pecaric-Petkovic, Svetlana A. Didichenko,
IFN-γ and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4+ but not CD8+ T cells by Joseph Barbi, Steve Oghumu, Claudio.
by Kathryn Lagrue, Alex Carisey, David J
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
by Yoko Otake, Sridharan Soundararajan, Tapas K. Sengupta, Ebenezer A
CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production by Giuseppe Sconocchia, Laura Campagnano, Domenico Adorno, Angela.
by Rosemary E. Smith, Vanshree Patel, Sandra D. Seatter, Maureen R
Autoimmune regulator (AIRE) contributes to Dectin-1–induced TNF-α production and complexes with caspase recruitment domain–containing protein 9 (CARD9),
by Rong He, Hairong Sang, and Richard D. Ye
Volume 9, Issue 5, Pages (November 1998)
Christopher L. Kepley, PhD, Bridget S. Wilson, PhD, Janet M
Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle  Ruijuan Tian, M.Sc., Zengyong.
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor–1α in macrophages via sphingosine-1-phosphate and transforming.
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages by Barbara Scheuerer, Martin Ernst,
CD74 induces TAp63 expression leading to B-cell survival
by Rong L. He, Jian Zhou, Crystal Z
Conjugation of Blocked Ricin to an Anti-CD19 Monoclonal Antibody Increases Antibody-Induced Cell Calcium Mobilization and CD19 Internalization by Anne-Christine.
Signal transduction pathways triggered by the FcϵRIIb receptor (CD23) in human monocytes lead to nuclear factor-κB activation  Rosa M. Ten, MD, PhDa,
CD6 Ligation Modulates the Bcl-2/Bax Ratio and Protects Chronic Lymphocytic Leukemia B Cells From Apoptosis Induced by Anti-IgM by Lyda M. Osorio, Angelina.
IL-10 disrupts the Brd4-docking sites to inhibit LPS-induced CXCL8 and TNF-α expression in monocytes: Implications for chronic obstructive pulmonary disease 
by Alexander Kiani, Francisco J
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells by Aleksandar Petlickovski,
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions by Claire Abbal, Martine Lambelet, Debora Bertaggia, Carole.
CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection by Rodolfo Silva, Susan Moir,
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies by Inés González-García,
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic.
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells by Sergey Krysov, Samantha Dias, Alex Paterson, C.
by Mi-Ae Kang, Su-Young Yun, and Jonghwa Won
TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow by Shoichiro Tsuji, Catarina Cortesão,
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.
Vascular endothelial growth factor stimulates protein kinase CβII expression in chronic lymphocytic leukemia cells by Simon T. Abrams, Benjamin R. B. Brown,
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis by Albert Gutierrez,
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression by Giovanna Borsellino, Markus Kleinewietfeld,
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival by Diana Starlets, Yael Gore, Inbal Binsky, Michal Haran, Nurit.
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function by Vânia Coelho, Sergey Krysov, Andrew.
Fas ligand+ fallopian tube epithelium induces apoptosis in both Fas receptor+ T lymphocytes and endometrial cells  Sebastian E. Illanes, M.D., Kevin Maisey,
CD19 controls Toll-like receptor 9 responses in human B cells
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells by Uri Rozovski, Ji Yuan Wu, David.
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion by John D. Belcher, Paul H. Marker,
Volume 124, Issue 5, Pages (May 2003)
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia by Shahrzad Jalali, Tammy Price-Troska, Jonas Paludo, Jose Villasboas, Hyo-Jin.
Volume 39, Issue 5, Pages (November 2013)
Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B- cell dysfunction in patients with Smith-Magenis syndrome  Javier Chinen,
Volume 15, Issue 6, Pages (December 2001)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Katherine G. MacDonald, BSc, Nicholas A. J
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sézary Syndrome  Heather M. Gibson, Anjali Mishra, Derek.
T-box 21 transcription factor is responsible for distorted TH2 differentiation in human peripheral CD4+ T cells  Osamu Kaminuma, DVM, PhD, Fujiko Kitamura,
by Kamira Maharaj, John J
by Silvia Mele, Stephen Devereux, Andrea G
Volume 125, Issue 4, Pages (May 2006)
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations  Giovanna.
A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization.
B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian.
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm by Hew Yeng Lai, Stefan A. Brooks,
by Defne Bayik, Debra Tross, Lydia A
Volume 33, Issue 1, Pages (July 2010)
Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease  Dominik Hartl, MD, Natalie Lehmann, MD, Florian Hoffmann, MD,
Senescence-associated defective HLA-DR upregulation does not modulate immunosuppressive properties of MSCs. (A) Fit and senescent MSCs were subjected to.
Regulation of IL-13 receptor α1 expression and signaling on human tonsillar B- lymphocyte subsets  Oumnia Hajoui, PhD, Huaien Zheng, MD, PhD, Julie Guay,
by Babs O. Fabriek, Robin van Bruggen, Dong Mei Deng, Antoon J. M
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
by Fabian C. Verbij, Nicoletta Sorvillo, Paul H. P
The channel-kinase TRPM7 regulates antigen gathering and internalization in B cells by Mithunah Krishnamoorthy, Laabiah Wasim, Fathima Hifza Mohamed Buhari,
Evidence for a cross-talk between human neutrophils and Th17 cells
Presentation transcript:

The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia by Christine Le Roy, Pierre-Antoine Deglesne, Nathalie Chevallier, Taoufik Beitar, Virginie Eclache, Maude Quettier, Marouane Boubaya, Rémi Letestu, Vincent Lévy, Florence Ajchenbaum-Cymbalista, and Nadine Varin-Blank Blood Volume 120(2):356-365 July 12, 2012 ©2012 by American Society of Hematology

Cell surface IgM levels as well as expression and global phosphorylation levels of Syk reflect CLL B-cell responsiveness. Cell surface IgM levels as well as expression and global phosphorylation levels of Syk reflect CLL B-cell responsiveness. Presence of surface IgM (A), CD20 (B), or Syk (C) and Zap70 (D) kinase levels was assayed on normal (control) and CLL B cells using flow cytometry analysis. (A) Cell surface IgM levels were calculated and graphed relative to control isotype labeling for 11 controls, 20 nonresponder (NR) samples, and 20 responder (R) samples. MFI indicates mean fluorescence intensity. (B-D) Cell surface CD20 expression on 20 NR and 20 R patients and intracellular Syk and Zap70 on 22 NR and 24 R cases were evaluated and graphed relative to control B cells. Means (± SEM) and significant P values are indicated (ns denotes not significant). (E) Anti-phosphotyrosine immunoprecipitation ([IP]; α-pY) was performed on cellular extracts of NR (n = 6) and R (n = 6) CLL B cells. Cells were either left unstimulated (−) or stimulated (+) with anti-IgM (α-IgM) antibody. Precipitates were analyzed with anti-Syk or anti-Zap70 antibodies, allowing detection of pSyk and pZap70. Total extracts are analyzed as a control for Syk and Zap70 expression. Fold increase is calculated as a ratio between stimulated and unstimulated levels. Christine Le Roy et al. Blood 2012;120:356-365 ©2012 by American Society of Hematology

BCR triggering promotes PLCγ2 phosphorylation and calcium mobilization in responding CLL B cells. BCR triggering promotes PLCγ2 phosphorylation and calcium mobilization in responding CLL B cells. (A) Phospho-Y759-PLCγ2 levels were analyzed using a specific PE-coupled antibody in CLL B cells (CD20+/CD5+/CD3−) by flow cytometry analysis. Histogram plots show pY759 PLCγ2 MFI in unstimulated (α-IgM−, top) and stimulated (α-IgM+, bottom) B cells from 1 representative patient for each CLL group (NR, left; R, right). Phospho-PLCγ2 was measured for 43 samples after 10 minutes of incubation with anti-IgM antibody in NR (n = 20, black dots) and R (n = 23, black squares) cases, calculated as fold induction over unstimulated cells and graphed. (B) Calcium release curves established in NR (n = 7, left) and R (n = 8, right) cases. After 60-second stabilization, CLL B cells were stimulated with anti-IgM antibody (+ α-IgM) followed at 290 seconds by ionomycin addition (+ ionomycin). Christine Le Roy et al. Blood 2012;120:356-365 ©2012 by American Society of Hematology

NFAT2 is overexpressed and to some extent localized into the nucleus of CLL B cells. NFAT2 is overexpressed and to some extent localized into the nucleus of CLL B cells. (A) Relative NFAT2 transcript levels were assessed by quantitative RT-PCR from freshly isolated normal blood peripheral B and T lymphocytes (normal lymphocytes B and T; n = 6 and n = 3, respectively) and from CLL B cells from NR and R cases (n = 17). NFAT levels were normalized to Abelson expression. (B) Freshly purified CLL B cells (n = 10) were immunostained with anti-NFAT2 antibody. Nuclei were counterstained with 4,6-diamidino-2-phenylindole. One representative case of each CLL group (NR and R) is presented. Images were acquired using confocal laser-scanning microscope (TCS SP2; Leica). Scale bars represent 5 μm. Single optical sections were obtained with high numerical aperture lens (63 × 2.8 NA) to determine the percentage of NFAT2-positive nuclei in NR and R cells and graphed on the right histogram; an average of 90 cells/sample (6 samples) were analyzed. No statistical difference was observed (ns). Christine Le Roy et al. Blood 2012;120:356-365 ©2012 by American Society of Hematology

On BCR ligation, NFAT2 is differentially activated in B cells from both groups of patients. On BCR ligation, NFAT2 is differentially activated in B cells from both groups of patients. (A) Nuclear or cytoplasmic extracts from freshly isolated B cells from R (n = 9) and NR (n = 6) cases and from unstimulated or CD3+/CD28+-stimulated Jurkat cell line (horizontal dashed lines) were analyzed for their NFAT2 DNA-binding ability using an ELISA-derived assay. Competition with a specific oligonucleotide was used to ensure binding specificity (P, probe; n = 3). No statistical difference (ns) was observed between NR and R patient extracts. (B) Nuclear extracts from NR (n = 13) and R (n = 12) cells stimulated or not with an anti-IgM antibody (10 μg/mL/106 cells) for 18 hours were used following the same protocol as described in panel A. Results are presented as fold induction of the NFAT2 DNA-binding ability on stimulation. Christine Le Roy et al. Blood 2012;120:356-365 ©2012 by American Society of Hematology

VIVIT peptide inhibitor blocks the BCR/NFAT-dependent pathway in responding CLL B cells. VIVIT peptide inhibitor blocks the BCR/NFAT-dependent pathway in responding CLL B cells. (A) NFAT2 immunofluorescence staining of CLL B cells from 1 representative R case (n = 3) stimulated or not in the presence or not of NFAT inhibitor 11-R VIVIT (5μM for 24 hours). Scale bar corresponds to 5 μm. (B) Quantitative RT-PCR analysis of CD23 transcript expression levels in freshly isolated B cells from R cases (n = 5) on stimulation with anti-IgM (10 μg/mL) in the presence or not of 11-R VIVIT (5μM). CD23 mRNA expression was normalized on ABL transcript expression in each tested sample, and results were graphed. Cell surface expression of CD23 protein (C) or CD71 protein (D) was determined using flow cytometry analysis on CLL cells from 7 (C) or 8 (D) R cases stimulated with anti-IgM (10 μg/mL) in presence of increasing concentrations (0, 2, and 5μM) of 11-R VIVIT. Levels are indicated as fold increase on stimulation. (E) Fold increase of metabolic activity (% MTS) was determined on 48-hour BCR stimulation for 13 NR and 12 R cases. B lymphocytes were incubated in the presence or not of 11-R VIVIT (5μM). Christine Le Roy et al. Blood 2012;120:356-365 ©2012 by American Society of Hematology

IgM-induced cell survival is relevant for CLL clinical outcome. IgM-induced cell survival is relevant for CLL clinical outcome. Kaplan-Meier plots showing PFS (A) and OS (B) distributions in R and NR patients. Log-rank test was used to compare statistical differences in PFS and survival between both groups (P values are indicated). Christine Le Roy et al. Blood 2012;120:356-365 ©2012 by American Society of Hematology